Soft Tissue and Uterine Leiomyosarcoma

Por George, Suzanne, Serrano, César, Hensley, Martee L., Ray-Coquard, Isabelle
Publicado no J Clin Oncol (2018)

Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial

Por Hensley, Martee L., Blessing, John A., Mannel, Robert, Rose, Peter G.
Publicado em 2008

Treatment of Advanced or Recurrent Endometrial Carcinoma with Doxorubicin in Patients Progressing after Paclitaxel/Carboplatin: Memorial Sloan-Kettering Cancer Center (MSKCC) Exper...

Por Makker, Vicky, Hensley, Martee L., Zhou, Qin, Iasonos, Alexia, Aghajanian, Carol. A.
Publicado em 2013

Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study

Por Hensley, Martee L., Blessing, John A., DeGeest, Koen, Abulafia, Ovadia, Rose, Peter G., Homesley, Howard D.
Publicado em 2008

A PHASE II EVALUATION OF TRABECTEDIN IN THE TREATMENT OF ADVANCED, PERSISTENT, OR RECURRENT UTERINE LEIOMYOSARCOMA: A GYNECOLOGIC ONCOLOGY GROUP STUDY

Por Monk, Bradley J., Blessing, John A., Street, Daron G., Muller, Carolyn Y., Burke, James J., Hensley, Martee L.
Publicado no Gynecol Oncol (2011)

Treatment of Advanced Uterine Leiomyosarcoma with Aromatase Inhibitors

Por O’Cearbhaill, Roisin, Zhou, Qin, Iasonos, Alexia, Soslow, Robert A., Leitao, Mario. M., Aghajanian, Carol, Hensley, Martee L.
Publicado no Gynecol Oncol (2009)

YWHAE-Rearranged High-Grade Endometrial Stromal Sarcoma: Two-Center Case Series and Response to Chemotherapy

Por Hemming, Matthew L., Wagner, Andrew J., Nucci, Marisa R., Chiang, Sarah, Wang, Lu, Hensley, Martee L., George, Suzanne
Publicado no Gynecol Oncol (2017)

Identifying Clinical Improvement in Consolidation Single-arm Phase II Trials in Ovarian Cancer Patients in Second or Greater Clinical Remission

Por Iasonos, Alexia, Sabbatini, Paul, Spriggs, David R., Aghajanian, Carol A., O’Cearbhaill, Roisin E., Hensley, Martee L., Thaler, Howard T.
Publicado em 2012

A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I–IV uterine carcinosarcoma

Por Makker, Vicky, Abu-Rustum, Nadeem R., Alektiar, Kaled M., Aghajanian, Carol. A., Zhou, Qin, Iasonos, Alexia, Hensley, Martee. L.
Publicado em 2008

Randomized Phase III Trial of Gemcitabine Plus Docetaxel Plus Bevacizumab or Placebo As First-Line Treatment for Metastatic Uterine Leiomyosarcoma: An NRG Oncology/Gynecologic Onco...

Por Hensley, Martee L., Miller, Austin, O'Malley, David M., Mannel, Robert S., Behbakht, Kian, Bakkum-Gamez, Jamie N., Michael, Helen
Publicado no J Clin Oncol (2015)

Eribulin mesylate (halichondrin B Analog E7389) in platinum-resistant and platinum-sensitive ovarian cancer: a two-cohort, phase II study

Por Hensley, Martee L., Kravetz, Sara, Jia, Xiaoyu, Iasonos, Alexia, Tew, William, Pereira, Lauren, Sabbatini, Paul, Whalen, Christin, Aghajanian, Carol A., Zarwan, Corinne, Berlin, Suzanne
Publicado em 2011

External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcoma

Por Iasonos, Alexia, Keung, Emily, Zivanovic, Oliver, Mancari, Rosanna, Peiretti, Michele, Nucci, Marisa, George, Suzanne, Colombo, Nicoletta, Carinelli, Silvestro, Hensley, Martee L., Raut, Chandrajit P
Publicado em 2013

Impact of Prophylactic Conversion to an Extended Infusion Schedule to Prevent Hypersensitivity Reactions in Ovarian Cancer Patients during Carboplatin Retreatment

Por O’Cearbhaill, Roisin, Zhou, Qin, Iasonos, Alexia, Hensley, Martee L., Tew, William P., Aghajanian, Carol, Spriggs, David R., Lichtman, Stuart M., Sabbatini, Paul J.
Publicado no Gynecol Oncol (2009)

A phase II, single arm study of iniparib in patients with BRCA1 or BRCA2 associated advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer

Por Bell-McGuinn, Katherine M., Konner, Jason A., Tew, William P., Hensley, Martee L., Iasonos, Alexia, Charpentier, Eric, Mironov, Svetlana, Sabbatini, Paul, Aghajanian, Carol
Publicado no Int J Gynecol Cancer (2016)

A phase 1 study of KOS-862 (Epothilone D) co-administered with carboplatin (Paraplatin(®)) in patients with advanced solid tumors

Por Monk, J. Paul, Villalona-Calero, Miguel, Larkin, Joe, Otterson, Greg, Spriggs, David S., Hannah, Alison L., Cropp, Gillian F., Johnson, Robert G., Hensley, Martee L.
Publicado no Invest New Drugs (2011)

Nomogram to Predict Cycle-One Serious Drug-Related Toxicity in Phase I Oncology Trials

Por Hyman, David M., Eaton, Anne A., Gounder, Mrinal M., Smith, Gary L., Pamer, Erika G., Hensley, Martee L., Spriggs, David R., Ivy, Percy, Iasonos, Alexia
Publicado em 2014

Sunitinib Malate in the treatment of recurrent or persistent uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study

Por Hensley, Martee L., Sill, Michael W., Scribner, Dennis R., Brown, Jubilee, DeBernardo, Robert L., Hartenbach, Ellen M., McCourt, Carolyn K., Bosscher, James R., Gehrig, Paola A.
Publicado em 2009

Classification and Regression Tree (CART) Analysis of Endometrial Carcinoma: Seeing the Forest for the Trees

Por Barlin, Joyce N., Zhou, Qin, St. Clair, Caryn M., Iasonos, Alexia, Soslow, Robert A., Alektiar, Kaled M., Hensley, Martee L., Leitao, Mario M., Barakat, Richard R., Abu-Rustum, Nadeem R.
Publicado em 2013

Pathologic Ultrastaging Improves Micrometastasis Detection in Sentinel Lymph Nodes during Endometrial Cancer Staging

Por Kim, Christine H., Soslow, Robert A., Park, Kay J., Barber, Emma L., Khoury-Collado, Fady, Barlin, Joyce N., Sonoda, Yukio, Hensley, Martee L., Barakat, Richard R., Abu-Rustum, Nadeem R.
Publicado em 2013

GCIG Consensus Review: Uterine and Ovarian Leiomyosarcomas

Por Hensley, Martee L., Barrette, Brigitte A., Baumann, Klaus, Gaffney, David, Hamilton, Anne L., Kim, Jae-Weon, Maenpaa, Johanna U., Pautier, Patricia, Siddiqui, Nadeem Ahmad, Westermann, Anneke M., Ray-Coquard, Isabelle
Publicado no Int J Gynecol Cancer (2014)